Nabla Bio Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Since its inception in 2021, Nabla Bio has pursued partnerships with leading pharmaceutical companies, including AstraZeneca, Bristol Myers Squibb, and Takeda, to advance opportunities in generative protein design. The company positions itself within the biotechnology research sector, leveraging both AI and laboratory capabilities to address previously intractable drug targets. Its activities are directed toward enabling deeper patient impact by providing collaborative avenues for drug discovery programs and expanding the potential target space available to the industry.